Deep Neural Network for Enhancing Drug-Utilization Clustering

  • Authors

    • Hadab Khalid Obayes
    • Nabeel Al – A'araji
    • Eman AL-Shamery
    2018-11-27
    https://doi.org/10.14419/ijet.v7i4.19.27990
  • Deep Neural Network, Drug Utilization, Disease_Drugs_Clustering_Deep_Nural_network.
  • Drug consumption data needs to be linked to the disease. The process of analyzing quantities consumed based on drug name and brand is complex. It needs to be accurate because it is involved in the provision, manufacture,and marketing of medicines. The aim of this paper is to obtain optimal clustersof the drugs according to utilization. Anew model is proposed for the clustering process, specifically the Disease_Drugs_Clustering_Deep_Nural_network (DDC_DNN) as a type of deep neural network. This model consists of four layers. In the first layer,the features have been adapted to the network weights. The normalization and standardization are satisfied in the second layer. The main contributions are concerned in the forming primal clusters according to neighbors' proximity and distance. In the third layer, the final clustering is organized by re-forming clusters depends on the calculation of cluster centers and merging of the nearest clusters according to a carefully selected threshold. Three diseases have been linked with their drugs to be the research data set (diabetes, leukemia,and allergy). The final clusters are optimal clusters. Silhouette validity score has been used to validate the quality of clusters. The result of the proposed model has been compared with the traditional method K-means. Silhouette score of the proposed model result was better than the result of the K-means for the data set.

     

     

  • References

    1. [1] M. I. Razzak, S. Naz, and A. Zaib, “Deep Learning for Medical Image Processing: Overview, Challenges and Future,†CoRR, vol. 1704.06825, pp. 1–30, 2017.

      [2] C. Company, “Chapter 5 Application of Data Mining Techniques in Data Mining Needs of Global,†pp. 138–180, 1990.

      [3] S. Madge, “Predicting Stock Price Direction using Support Vector Machines,†2015.

      [4] J.-G. Lee et al., “Deep Learning in Medical Imaging: General Overview,†Korean J. Radiol., vol. 18, no. 4, p. 570, 2017.

      [5] Zhaojin Zhang, Cunlu Xu, and Wei Feng, “Road vehicle detection and classification based on Deep Neural Network,†2016 7th IEEE Int. Conf. Softw. Eng. Serv. Sci., no. 60903101, pp. 675–678, 2016.

      [6] O. Pattanaprateep, M. McEvoy, J. Attia, and A. Thakkinstian, “Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; Association rule data mining using outpatient prescription patterns,†BMC Med. Inform. Decis. Mak., vol. 17, no. 1, pp. 1–7, 2017.

      [7] M. Sultana, A. Haider, and M. S. Uddin, “Analysis of data mining techniques for heart disease prediction,†2016 3rd Int. Conf. Electr. Eng. Inf. Commun. Technol. iCEEiCT 2016, 2017.

      [8] S. Perveen, M. Shahbaz, A. Guergachi, and K. Keshavjee, “Performance Analysis of Data Mining Classification Techniques to Predict Diabetes,†Procedia Comput. Sci., vol. 82, no. March, pp. 115–121, 2016.

      [9] O. G. D. Fy, R. Science, I. Effective, T. Office, and G. Drugs, “FYs 2013 - 2017 Regulatory Science Report : Analysis of Generic Drug Utilization and Substitution,†no. Figure 1, pp. 1–10, 2017.

      [10] Y. Zhou, N. Sani, C.-K. Lee, and J. Luo, “Understanding Illicit Drug Use Behaviors by Mining Social Media,†2016 IEEE Int. Conf. Big Data (Big Data), 2016.

      [11] R. Ghousi, S. Mehrani, and M. Momeni, “Application of Data Mining Techniques in Drug Consumption Forecasting to Help Pharmaceutical Industry Production Planning,†Proc. 2012 Int. Conf. Ind. Eng. Oper. Manag., pp. 1162–1167, 2012.

      [12] Y. Lecun, Y. Bengio, and G. Hinton, “Deep learning,†Nature, vol. 521, no. 7553, pp. 436–444, 2015.

      [13] E. AL-Shamery and A. AL-haq, “An Optimized Feed Forward Neural Network for Reducing Error Based Stoch Market Prediction,†J. Eng. Appl. Sci., vol. 13, no. Special Issue 5, pp. 4616–4621, 2018.

      [14] S. Storcheus, Dmitry; Rostamizadeh, Afshin; Kumar, “A Survey of Modern Questions and Challenges in Feature Extraction,†1st Int. “Feature Extr. Mod. Quest. Challenges,†vol. 44, pp. 1–18, 2015.

      [15] E. AL-Shamery and A. AL-haq, “Enhancing Prediction of NASDAQ Stock Market Based on Technical Indicators,†J. Eng. Appl. Sci., vol. 13, no. Special Issue 5, pp. 4630–4636, 2018.

      [16] A. Abebe, J. Daniels, W. McKean, and A. Kapenga, Statistics and Data Analysis. Kalamazoo, MI: Western Michigan University, 2001.

      [17] H. Khalid Obayes, “Suggested Approach to Embedded Playfair Cipher Message in Digital Image,†vol. 3, no. 5, pp. 710–714, 2013.

      [18] Z. Ansari, M. F. Azeem, W. Ahmed, and A. V. Babu, “Quantitative Evaluation of Performance and Validity Indices for Clustering the Web Navigational Sessions,†vol. 1, no. 5, pp. 217–226, 2015.

      [19] J. Baarsh and M. E. Celebi, “Investigation of Internal Validity Measures for K-Means Clustering,†Proc. Interational MultiConference Eng. Comput. Sci., vol. I, pp. 14–16, 2012.

  • Downloads

  • How to Cite

    Khalid Obayes, H., Al – A'araji, N., & AL-Shamery, E. (2018). Deep Neural Network for Enhancing Drug-Utilization Clustering. International Journal of Engineering & Technology, 7(4.19), 732-737. https://doi.org/10.14419/ijet.v7i4.19.27990